Remedium Lifecare Ltd
₹ 723
-0.07%
28 Sep
9:09 a.m.
About
Incorporated in 1988, Remedium Lifecare Ltd is in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products
Key Points
- Market Cap ₹ 1,458 Cr.
- Current Price ₹ 723
- High / Low ₹ 898 / 24.4
- Stock P/E 256
- Book Value ₹ 5.13
- Dividend Yield 0.00 %
- ROCE 103 %
- ROE 71.0 %
- Face Value ₹ 5.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has a good return on equity (ROE) track record: 3 Years ROE 44.6%
Cons
- Stock is trading at 141 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 1.11%
- Debtor days have increased from 88.6 to 123 days.
- Promoter holding has decreased over last 3 years: -42.5%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 2 | 4 | 1 | 0 | 0 | 3 | 90 | 505 | 510 | 741 | |
1 | 1 | 2 | 4 | 1 | 0 | 0 | 2 | 89 | 503 | 502 | 733 | |
Operating Profit | 0 | 0 | -0 | -0 | -0 | 0 | -0 | 0 | 1 | 2 | 8 | 8 |
OPM % | 7% | 3% | -8% | -8% | -7% | 0% | -44% | 14% | 1% | 0% | 2% | 1% |
0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 7 | 8 |
Tax % | 0% | 50% | 21% | 0% | 0% | 0% | 100% | 24% | 26% | 29% | 27% | |
0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 4 | |
EPS in Rs | 0.01 | 0.00 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.24 | 0.53 | 2.69 | 2.06 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 329% |
3 Years: | 461% |
TTM: | 59% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 252% |
3 Years: | 169% |
TTM: | -20% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 169% |
3 Years: | 400% |
1 Year: | 2847% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 45% |
Last Year: | 71% |
Balance Sheet
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |
Reserves | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -0 | 0 | 1 | 7 |
1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | |
2 | 1 | 3 | 2 | 0 | 0 | 0 | 1 | 24 | 219 | 1,144 | |
Total Liabilities | 6 | 6 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 1,154 |
2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
4 | 4 | 4 | 5 | 3 | 3 | 4 | 4 | 38 | 224 | 1,154 | |
Total Assets | 6 | 6 | 6 | 5 | 3 | 3 | 4 | 4 | 39 | 224 | 1,154 |
Cash Flows
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | -1 | 0 | -0 | -0 | -0 | -10 | 11 | 20 | |||
0 | 1 | 0 | 0 | 1 | -0 | -0 | -0 | -0 | |||
-0 | -0 | 0 | 0 | 0 | 0 | 10 | -11 | -0 | |||
Net Cash Flow | -0 | 0 | 0 | -0 | 1 | -0 | -0 | 1 | 20 |
Ratios
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 203 | 120 | 341 | 265 | 596 | 2,117 | 319 | 189 | 96 | 46 | 123 |
Inventory Days | 1,506 | 1,129 | 243 | 78 | 0 | 0 | 5 | ||||
Days Payable | 162 | 102 | 438 | 129 | 62 | ||||||
Cash Conversion Cycle | 1,547 | 1,147 | 146 | 214 | 596 | 2,117 | 319 | 189 | 96 | 46 | 67 |
Working Capital Days | 607 | 566 | 107 | 200 | 524 | 2,159 | 4,745 | 323 | 54 | 2 | -8 |
ROCE % | 1% | 1% | 0% | 1% | 1% | 11% | 7% | 18% | 103% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
8 Sep - Resignation of Ms.Ashvini Dhuri(Membership No.A66051), as a Company Secretary & Compliance Officer of the Company.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 6 Sep
- Announcement under Regulation 30 (LODR)-Resignation of Director 5 Sep
- Announcement under Regulation 30 (LODR)-Change in Directorate 5 Sep
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 05.09.2023. 5 Sep
Business Overview:[1]
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets